↓ Skip to main content

Dove Medical Press

Article Metrics

Optimal management of digital ulcers in systemic sclerosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
10 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
29 Mendeley
Title
Optimal management of digital ulcers in systemic sclerosis
Published in
Therapeutics and Clinical Risk Management, June 2015
DOI 10.2147/tcrm.s82561
Pubmed ID
Authors

Virginia Steen, Shawn Abraham

Abstract

Raynaud's phenomenon and digital ulcerations are two common clinical features seen in patients with systemic sclerosis. They are painful and lead to significant morbidity and altered hand function within this patient population. While currently there are no US Food and Drug Administration (FDA)-approved medications for the treatment of digital ulcerations in the United States, clinical trials have supported the use of pharmacologic and nonpharmacologic modalities in facilitating healing of existing digital ulcers and preventing formation of new ulcers. This article reviews the published data on these therapeutic options.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 3%
France 1 3%
Unknown 27 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 21%
Unspecified 4 14%
Student > Ph. D. Student 4 14%
Student > Bachelor 3 10%
Student > Postgraduate 3 10%
Other 9 31%
Readers by discipline Count As %
Medicine and Dentistry 18 62%
Unspecified 4 14%
Computer Science 1 3%
Business, Management and Accounting 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 4 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2018.
All research outputs
#1,883,289
of 13,306,000 outputs
Outputs from Therapeutics and Clinical Risk Management
#82
of 960 outputs
Outputs of similar age
#38,283
of 232,862 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 46 outputs
Altmetric has tracked 13,306,000 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 960 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,862 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.